baber/WOPTO huggingface dataset:
Patent AT-E213168-T1 (AT)
Inventor: DEAN RICHARD T
IPC: A61K51/00
Filed: 1992-11-19
Granted: 2002-02-15
Abstract: This invention relates to therapeutic reagents and peptides, including radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled radiodiagnostic agents. Specifically, the invention relates to cyclic peptide derivatives and analogs of somatostatin, and embodiments of such peptides radiolabeled with a radioisotope, as well as methods and kits for making, radiolabeling and using such peptides for radiodiagnostic and radiotherapeutic purposes. The invention specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with technetium-99m and uses thereof as scintigraphic imaging agents. The invention also specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with cytotoxic radioisotopes such as rhenium-186 (186Re) and rhenium-188 (188Re) for use as radiotherapeutic agents. Methods and kits for making, radiolabeling and using such peptides diagnostically and therapeutically in a mammalian body are also provided.
Patent AT-E187613-T1 (AT)
Inventor: FOLDENAUER WILLI DR
IPC: A46B15/00
Filed: 1993-03-11
Granted: 2000-01-15
Abstract: A rod-like device (1), especially a toothbrush (1) or a writing instrument, has a labelling device facilitating individual marking of the rod-like device (1). In a variant of the invention, the labelling device has a movable marking element (8, 10, 12, 13, 14) and letters (6) and/or figures.
Patent AT-E147664-T1 (AT)
Inventor: HAUSER JEAN-LUC
IPC: A61M11/00
Filed: 1993-04-28
Granted: 1997-02-15
Abstract: PCT No. PCT/FR93/00411 Sec. 371 Date Dec. 28, 1993 Sec. 102(e) Date Dec. 28, 1993 PCT Filed Apr. 28, 1993 PCT Pub. No. WO93/22068 PCT Pub. Date Nov. 11, 1993.An acoustic micropulverization device for the formation of microdroplets is disclosed having a cell that contains a propagating medium having an attenuation less than or equal to about 1 dB/cm. One wall of the cell comprises an ultrasonic generator. Another wall of the cell contains a reflective surface that operates to focus ultrasonic waves upward toward a point that is near the top surface of a liquid that is contained in a reservoir located above the cell, thereby producing microdroplets above the liquid's top surface. A chamber is located over the top surface of the liquid. This chamber includes means for diffusing the microdroplets.
Patent AT-E157176-T1 (AT)
Inventor: THOGERSEN JAN
IPC: G02F2/00
Filed: 1993-06-15
Granted: 1997-09-15
Abstract: The object of the invention is to provide a method which makes it possible to determine the correlation between two optical signals, which makes it possible to correlate two optical signals, without using a crystal element which is associated with a plurality of drawbacks, because the components are quite expensive. It has been found possible to replace a frequency doubling crystal by an active, optical wave guide, e.g. in the form of an active, optical fiber, said wave guide transmitting fluorescence which is intensity-related to the arrived signal. When this fluorescence is detected in spectral bands, e.g. in the blue region of the visible light, an image of the strength of the arriving signal may be formed. Current distance delaying of the two correlated signals makes it possible to produce an image of the correlation between the signals.
Patent AT-E184362-T1 (AT)
Inventor: FLAMME HANS
IPC: E05D5/02
Filed: 1993-06-09
Granted: 1999-09-15
Abstract: PCT No. PCT/EP93/01472 Sec. 371 Date Dec. 7, 1994 Sec. 102(e) Date Dec. 7, 1994 PCT Filed Jun. 9, 1993 PCT Pub. No. WO93/25790 PCT Pub. Date Dec. 23, 1993The invention concerns a hinge, in particular a hinge for switch-cabinet and instrument-cabinet doors, the hinge comprising a part fitted to the door and a part fitted to the cabinet which engage with each other for rotational motion by means of at least one hinge pin. In order to ensure that the hinge parts can be separated and reassembled rapidly and simply, the invention calls for at least one hinge part (10, 40) to be designed in two elements, via a first and a second element (11, 12; 41, 42) and that the first and second element (11, 12; 41, 42) can be displaced relative to each other in the longitudinal direction to enable the other part (20; 50) to be inserted and withdrawn again.
Patent AT-E148491-T1 (AT)
Inventor: GUICHARD PHILIPPE
IPC: B01J23/85
Filed: 1993-10-25
Granted: 1997-02-15
Abstract: A process for the preparation of a lubricating base oil including contacting a hydrocarbon feed with a catalyst in the presence of hydrogen, which catalyst includes a hydrogenation component supported on an amorphous silica-alumina carrier having a macroporosity in the range of from 5% vol to 50% vol. The hydrocarbon feed is most preferably a slack wax or a synthetic wax. The preferred catalyst for use in the process includes a combination of one or more of the metals cobalt, iron, and nickel, and one or more of the metals chromium, molybdenum, and tungsten on an amorphous silica-alumina carrier having a macroporosity in the range of from 5% vol to 50% vol.
Patent AT-E174745-T1 (AT)
Inventor: STERN MORTON
IPC: H04W16/06
Filed: 1988-07-18
Granted: 1999-01-15
Abstract: An existing cellular system (X-system 102) is interconnected with another cellular system (M-system 101) via inter-office trunks (150) to add additional switching capacity for providing telephone coverage to mobiles located throughout their common coverage area. X-system (102) includes a control terminal (120) coupled by data and voice lines to base sites (121-124) and by out trunks to a telephone central office (110). M-system (101) includes a control terminal (420) coupled by data and voice lines to base sites (411-415) and by in trunks and out trunks to the telephone central office (110). M-system base sites (411-414) are colocated with corresponding existing X-system base sites (121-124). Paging/access channels are assigned to M-system base sites (411-414) for processing all incoming originations from mobiles and paging mobiles for all outgoing originations. Access-only channels are assigned to X-system base sites (121-124) for processing mobile originations transferred to X-system (102) by a directed retry message from M-system (101). M-system (101) shares the mobile origination traffic with X-system (102) by sending a directed retry message to a percentage of the originating mobiles. <IMAGE>
Patent AT-E193393-T1 (AT)
Inventor: KONISHI AKIO
IPC: G11B15/665
Filed: 1990-10-11
Granted: 2000-06-15
Abstract: A tape loading device of a magnetic recording/reproducing apparatus, is characterized by including: first and second tape guide posts (9,11) for taking a tape (14), extending between a supply side reel (3) and a winding side reel (4) of a tape cassette (2), from the tape cassette and travelling the tape to a predetermined position located outside the tape cassette; first and second loading guides (19,20) for respectively guiding travels of the first and second tape guide posts to take out the tape from the tape cassette to the predetermined position; a common guide (22) for joining a part of the first loading guide and a part of second loading guide into the same path so as to guide the first and second loading guides in order; and a branch pointer arm (24,25) for switching between the common guide and the first and second loading guides, the branch pointer arm being urged to open one loading guide of the loading guides and close the other loading guide thereof, and pressed by one tape guide post of the tape guide posts when the tape guide post, moving along the common guide in precedence to the other tape guide post, has guided by the one loading guide which has been opened, whereby the one loading guide is closed and the other loading guide is opened to guide the other tape guide post of the tape guide posts. <IMAGE>
Patent AT-E196905-T1 (AT)
Inventor: ADDOR ROGER WILLIAMS
IPC: A01N43/08
Filed: 1994-08-17
Granted: 2000-10-15
Abstract: There are provided thienyl- and furylpyrrole compounds of formula I   <CHEM>  wherein   R, R1 and R2   are each independently hydrogen, halogen, NO2 or CHO, and when R1 and R2 are taken together with the carbon atoms to which they are attached, they may form a ring in which R1R2 is represented by the structure: <CHEM>   L, T, V and W   are each independently hydrogen, halogen, CN or NO2; A   is O or S; X   is CN, NO2, C1-C6 haloalkyl, S(O)mCF2R3 or C(S)NR4R5; R3   is hydrogen, F, Cl, Br, CF2H, CCl2H, CClFH, CF3 or CCl3; m   is an integer of 0, 1 or 2; R4 and R5   are each independently hydrogen, C1-C4 alkyl optionally substituted with one or more halogen atoms, or  phenyl optionally substituted with one or more halogen atoms,  NO2 groups,  CN groups, C1-C4 alkyl groups optionally substituted with one or more halogen atoms, or C1-C4 alkoxy groups optionally substituted with one or more halogen atoms; Y   is hydrogen, halogen, C1-C6 haloalkyl, S(O)mCF2R3, CN or  phenyl optionally substituted with one or more halogen atoms,  NO2 groups,  CN groups, C1-C4 alkyl groups optionally substituted with one or more halogen atoms, or C1-C4 alkoxy groups optionally substituted with one or more halogen atoms; Z   is hydrogen, halogen or C1-C6 haloalkyl; B   is R6, OR6 or CN; R6   is as defined in the specification provided that when A is S, X is S(O)mCF2R3 and Z is hydrogen, then Y is hydrogen, halogen, C1-C6 haloalkyl, S(O)mCF2R3 or CN; and further provided that when the pyrrole ring is substituted with hydrogen at each of the pyrrole carbon atoms adjacent to the ring nitrogen atom, then X cannot be CN or NO2, and their use for the control of insects and acarina.   Further provided are compositions and methods comprising those compounds for the protection of plants from attack by insects and acarina.
Patent AT-E175969-T1 (AT)
Inventor: WERBITZKY OLEG DR
IPC: C07D471/04
Filed: 1994-11-10
Granted: 1999-02-15
Abstract: Bicyclic amidines of formula (I) prepn. comprises: a) heating a lactone of formula (II) to at least 150 degrees C., with an at least equimolecular amt. of an amine of formula (III): b) isolating the prod. by distn., without isolation of an intermediate: (III) H2N-B-NH2. A = CR<1>R<2>-CR<3>R<4>-CR<5>R<6>-, -CR<1>R<2>-CR<3>R<4>-CR<5>R6-CR<7>R<8>, -CR<1>R<2>-CR<3>R<4>-CR<5>R<6>- CR<7>R<8>-CR<9>R<10>; B = CR<11>R<12>-CR<13>R<14>-, -CR<11>R<12>-CR<15>R<16>-CR<13>R<14>, -CR<11>R<12>-CR<15>R<16>-CR<17>R<18>-CR<13>R<14>; R<1>, R<2> and R<11> = H, 1-4C alkyl opt. substd. with OH or amino, aryl or 1-4C alkylamino or mercapto; and R<3-10> and R<15>-<18> = H, 1-4C alkyl, aryl, OH, amino, 1-4C alkylamino or mercapto, or 1-4C alkyl substd. with OH, amino or 1-4C alkylamino or mercapto. Also claimed are: (a) a bicyclic amidine; (b) new cpd.: 3-amino-2,3,4,6,7,8-hexahydropyrrolo(1,2-a)-pyrimidine (IV); (c) 3-(aminomethyl)2,5,6,7-tetrahydro-3H-pyrrolo(1,2-a)imidazole (V); and (d) 3-(aminomethyl)-3,2,3,4,6,7,8-hexahydropyrrolo(1,2-a)pyrimidine (VI); and (e) use of a bicyclic amidine as a catalyst.
Patent AT-E160281-T1 (AT)
Inventor: ZAUNER JEAN-LUC
IPC: A61F13/15
Filed: 1994-01-14
Granted: 1997-12-15
Abstract: The invention relates to a sanitary towel or the like, in particular for female hygiene, comprising a fluid-absorbent pad element arranged inside a cover, at least the fluid-collection part of which is fluid-permeable, side flaps (11, 12) being provided in order to improve performance and lateral leaktightness, the said side flaps being sufficiently large to be folded down on the outside around the underwear on the body, such as panties, worn by the user, characterised in that the side flaps (11, 12) are folded down onto the pad element about first fold lines (110, 120) and folded onto themselves outwards about second fold lines (111, 121), protective means (4) covering adhesive attachment means (31, 32) are provided on at least one of the two flaps (11, 12) and protective means (4) cover the said attachment means. The fold lines (111, 121) preferably form between them a space uncovering a central band (30) which is optionally coated with adhesive. <IMAGE>
Patent AT-E129043-T1 (AT)
Inventor: BARBIER DANIEL
IPC: E04B7/16
Filed: 1994-05-20
Granted: 1995-10-15
Abstract: The profile section includes a bearing central body and several superposed sets of two lateral wings which are symmetric to one another relative to the bearing central body. According to the invention, the bearing central body is a solid body (2) duplicated at the bottom in the shape of a fork, the two legs (6, 7) of which are symmetric relative to the plane (AA') passing through the top part of the said solid body; the profile section further comprises:   a) at least four sets of two wings, two (9, 10) in the region of the top part and two (11, 12) in the region of the duplicated bottom part of the central body, b) two lateral hollow bodies (14a, 14b) of a single piece with the central body, each being respectively formed of the two superposed wings (10a, 11a) of the two middle sets (10, 11) and a joining face (13a) connecting the ends of the two said wings.   Application: producing removable roofing structures, and more particularly roofing structures for pools where the roof can be opened up. <IMAGE>
Patent AT-E176755-T1 (AT)
Inventor: MYERS GARY LYNN
IPC: A61K8/02
Filed: 1993-11-15
Granted: 1999-03-15
Abstract: This invention relates to aerosol hair spray formulations based on (1) a sulfonate-containing, water-dispersible or water-dissipatible, linear polyester having a glass transition temperature of about 36 DEG  C. to about 40 DEG  C. and (2) a water-soluble, polyvinyl lactam polymer. In addition, the formulations contain water as the liquid vehicle and a propellant. Such aerosol hair spray formulations do not contain any volatile organic compounds other than propellant yet exhibit fast drying times and excellent performance characteristics.
Patent AT-E158504-T1 (AT)
Inventor: BRU-MAGNIEZ NICOLE
IPC: A61K9/14
Filed: 1993-12-09
Granted: 1997-10-15
Abstract: The present invention relates to a novel pharmaceutical composition for the preparation of effervescent powders or tablets incorporating ibuprofen or one of its pharmaceutically acceptable salts as the active ingredient. This composition comprises: an effective amount of ibuprofen or one of its pharmaceutically acceptable salts; a pharmaceutically acceptable effervescent system comprising at least one alkaline carbonate and at least one organic acid, preferably in a sufficient amount to give a pH below about 8; and at least one pharmaceutically acceptable antioxidant in a sufficient amount to stabilize the ibuprofen. This composition has a remarkable stability both in powder form and in tablet form.
Patent AT-E162993-T1 (AT)
Inventor: BAKX MARTINUS
IPC: B65D71/12
Filed: 1993-11-22
Granted: 1998-02-15
Abstract: A keel structure in a wraparound carton comprises a number of keel elements (K) which separate one row of containers from another row within the carton. Each keel element has spaced upstanding panels (P, 32; Pa, 32a) against which containers held in the carton abut. Each of the upstanding panels is spaced from the other by a platform (P1, P1a) defined by curved edges (C, C1; Ca, C1a) extending towards one another permitting adjacent portions of each of said upstanding panel means to be flexed inwardly toward the other to receive a wall portion of an adjacent container.
Patent AT-E159176-T1 (AT)
Inventor: WAGNER WOLFGANG DR
IPC: A61M1/00
Filed: 1994-03-02
Granted: 1997-11-15
Abstract: PCT No. PCT/EP94/00613 Sec. 371 Date Sep. 1, 1995 Sec. 102(e) Date Sep. 1, 1995 PCT Filed Mar. 2, 1994 PCT Pub. No. WO94/20152 PCT Pub. Date Sep. 15, 1994The invention concerns a drainage device for removing fluids by suction from body cavities, in particular from pleural cavity (12), the device having a drainage line (52) for removing the fluids by suction and a device (84) for creating an underpressure in the body cavity. The invention calls for an auxiliary line (54) whose channel at the patent end is in fluid contact with the channel of the drainage line (52), and for a gas to be supplied to the body cavity through the auxiliary line. The drainage device proposed enables troubles in drainage to be avoided and ensures that the drainage system is not obstructed.
Patent AT-E170402-T1 (AT)
Inventor: HART CHARLES E
IPC: C12N15/09
Filed: 1994-02-17
Granted: 1998-09-15
Abstract: Methods of inhibiting intimal hyperplasia in the vasculature of mammals, including primates, are disclosed. The methods comprise administering to the mammal an anti-PDGF receptor antibody, such as an anti-PDGF-alpha receptor antibody or an anti-PDGF-beta receptor antibody. The methods are useful in reducing intimal hyperplasia due to, for example, vascular injuries resulting from angioplasty, endarterectomy, reduction atherectomy or anastomosis of a vascular graft.
Patent AT-E214103-T1 (AT)
Inventor: NAKAMURA JUNJI
IPC: C12Q1/25
Filed: 1994-05-13
Granted: 2002-03-15
Abstract: A method of examining hormone-dependent tumors which comprises culturing tumor tissues in each of (a) a medium, (b) a medium containing a hormone synthetase substrate, and (c) a medium containing both a hormone synthetase substrate and a hormone synthetase inhibitor, measuring the growth rate of tumor cells in each medium, determining (i) the ratio of the growth rate of tumor cells in the presence of a hormone synthetase substrate to that in a medium alone and (ii) the ratio of the growth rate of tumor cells in the presence of both a hormone synthetase substrate and a hormone synthetase inhibitor to that in a medium alone. This method enables judging whether there are any hormone synthetase and hormone-dependent growth of hormone-dependent tumors readily at the same time. Further it can be employed for developing a new method of classifying tumors and selecting a guide line for tumor therapy.
Patent AT-E187067-T1 (AT)
Inventor: SAMUELS GLENN JAY
IPC: A61K31/5377
Filed: 1994-05-10
Granted: 1999-12-15
Abstract: Mycophenolate mofetil and mycophenolic acid can be conveniently manufactured into high dose oral formulations by the hot melt filling of a supercooled mycophenolate mofetil or mycophenolic acid liquid into a pharmaceutical dosage form. High dose oral pharmaceutical formulations and manufacturing methods therefor are disclosed.
Patent AT-E205518-T1 (AT)
Inventor: MIZUTANI MANABU MITSUI CYTEC L
IPC: C09D133/06
Filed: 1994-06-02
Granted: 2001-09-15
Abstract: An aqueous resin composition for can exterior coating, which is excellent in retorting resistance, hardness and processability, reduced in fuming, and comprising 30-70 parts by weight of a cross-linking agent (A) and 70-30 parts by weight of a film-forming resin (B). The component (A) comprises a cocondensate of an alkyl-etherified amino resin with a hydroxy carboxylic acid. The component (B) comprises an acrylate or polyester resin. It is necessary that both components can be dissolved or dispersed in an aqueous medium.
Patent AT-E161259-T1 (AT)
Inventor: WAETJEN FRANK
IPC: C07D241/44
Filed: 1994-05-09
Granted: 1998-01-15
Abstract: The present patent application discloses compounds having formula (I) or a pharmaceutically acceptable salt thereof wherein R<1> is hydrogen, alkyl or benzyl; X is O or NOR<2>, wherein R<2> is hydrogen, alkyl or benzyl; Y is N-R<4> wherein R<4> is hydrogen, OH or alkyl; n is 0 or 1; R<6> is phenyl, naphthyl, thienyl, pyridyl, all of which may be substituted one or more times with substituents selected from the group consisting of halogen; CF3, NO2, amino, alkyl, alkoxy and phenyl; A is a ring of five to seven atoms fused with the benzo ring at the positions marked a and b. The compounds are useful in the treatment of cerebrovascular disorders for example.
Patent AT-E264099-T1 (AT)
Inventor: KYLE DAVID JOHN
IPC: C12N1/00
Filed: 1994-06-02
Granted: 2004-04-15
Abstract: A method for treating a neurological disorder comprises administering to a person affected from such a disorder a microbial oil comprising docasahexaneoic acid (DHA), a microbial oil comprising arachidonic acid (ARA) or a combination of DHA and ARA oils in an amount sufficient to elevate the levels of circulating DHA and/or ARA in the person's blood to at least normal levels.
Patent AT-E158448-T1 (AT)
Inventor: JENNINGS HOWARD TIMOTHY
IPC: H02J15/00
Filed: 1994-07-06
Granted: 1997-10-15
Abstract: An energy conversion and storage device which comprises a rotor (5) comprising a tubular body portion and a stator (7) comprising one or more electric coils whereby electrical energy may be applied to and extracted from the device when the rotor (5) is rotating relative to the stator (7), the stator (7) being disposed within the rotor (5) co-axially therewith and means (13, 14, 15, 17) for electromagnetically suspending the rotor (5) whilst rotating relative to the stator (7), wherein the said suspension means includes active electromagnetic bearings (15, 17) at least one of which comprises at least one electromagnet comprising a control coil (L1) for controlling suspension of the rotor (5) and means (L2) electrically connected to the control coil (L1) but not forming a separate transducer for sensing a parameter related to the position of the rotor (5) and relative to the electromagnet (15, 17).
Patent AT-E208598-T1 (AT)
Inventor: LIERMAN JAMES C
IPC: A61J7/00
Filed: 1994-09-14
Granted: 2001-11-15
Abstract: A sealed holder and overcap assembly for a medicated matrix is provided. The overcap has an open end and is configured so that the entire holder may be removably positioned inside the overcap. The medicated matrix, which is disposed on the holder, is protected by sealing the open end of the overcap with a manually removable seal.
Patent AT-E181947-T1 (AT)
Inventor: PFALLER HARALD DR
IPC: C01F11/18
Filed: 1995-04-10
Granted: 1999-07-15
Abstract: Mineral filler (I) contg. carbonate, esp. natural and/or pptd. CaCO3, has the particle size distribution: 100% finer than 61 microns, 95-100% finer than 56 microns, 90-100% finer than 40 microns, 49-95% finer than 20 microns, 15-52% finer than 10 microns, 9-28% finer than 10 microns and 0-10% finer than 1 micron; and a d50 value of 9.6-20.5 microns.
Patent AT-E230270-T1 (AT)
Inventor: INAGI TOSHIO
IPC: A61K33/18
Filed: 1995-06-09
Granted: 2003-01-15
Abstract: A powder preparation for healing damaged skins, which comprises 50-90 wt.% of sucrose, 0.5-10 wt.% of povidone-iodine, and a water-soluble polymer selected from the group consisting of polyvinyl alcohol, polyvinyl pyrrolidone, polyacrylic acid and salts thereof, pullulan, carboxyvinyl polymers, methylcellulose, hydroxymethylcellulose, hydroxypropylmethylcellulose, and carboxymethylcellulose and salts thereof, is disclosed. The powder preparation features that it undergoes no caking even when vibrated upon its transportation or the like or stored for a long period of time, does not scatter upon its use, and has good adhesion to wound surfaces.